Measuring health-related quality of life in clinical trials in cystic fibrosis

被引：26

作者：

Abbott, J. ^{[1
]}

Hart, A.

Havermans, T. ^{[2
]}

Matossian, A. ^{[3
]}

Goldbeck, L. ^{[4
]}

Barreto, C. ^{[5
]}

Bergsten-Brucefors, A. ^{[6
]}

Besier, T. ^{[4
]}

Catastini, P. ^{[7
]}

Lupi, F. ^{[8
]}

Staab, D. ^{[9
]}

机构：

[1] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England

[2] Univ Hosp Leuven, B-3000 Louvain, Belgium

[3] Erasme Univ Hosp, B-1070 Brussels, Belgium

[4] Univ Clin Ulm, D-89075 Ulm, Germany

[5] Univ Hosp Santa Maria, P-1649035 Lisbon, Portugal

[6] Huddinge Univ Hosp, SE-14186 Stockholm, Sweden

[7] Univ Florence, Meyer Hosp, I-50132 Florence, Italy

[8] Univ Bologna, I-40127 Bologna, Italy

[9] Charite Humboldt Univ, D-10117 Berlin, Germany

来源：

JOURNAL OF CYSTIC FIBROSIS | 2011年 / 10卷

关键词：

Cystic fibrosis; Clinical trial; Quality of life measurement; Patient-reported outcome; QUESTIONNAIRE; ADOLESCENTS; VALIDATION; ADULTS; SATISFACTION;

D O I：

10.1016/S1569-1993(11)60013-1

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The inclusion of health-related quality of life (HRQoL) as an outcome measure in cystic fibrosis (CF) clinical trials can supply important patient-reported information not captured by other endpoints. Both an appropriate HRQoL measure and sound methodology are required in order to draw valid inferences about treatments and HRQoL. This paper provides the current consensus of the HRQoL Outcomes Group. Particular consideration has been given to the appropriateness of measurement scales, the rationale for including specific domains as endpoints, the importance of considering baseline ceiling effects and the difficulties of data interpretation. Guidance is provided on HRQoL measurement in National and European CF clinical trials. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

引用

页码：S82 / S85

页数：4

共 50 条

[1] Health-related quality of life in cystic fibrosis
Royce, Frederick H.
Carl, John C.
[J]. CURRENT OPINION IN PEDIATRICS, 2011, 23 (05) : 535 - 540
[2] MEASURING WHAT MATTERS: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CYSTIC FIBROSIS
Ruseckaite, R.
Ratnayake, I
Ahern, S.
[J]. PEDIATRIC PULMONOLOGY, 2019, 54 : S241 - S241
[3] MEASURING HEALTH-RELATED QUALITY OF LIFE FACTORS AT VCU CYSTIC FIBROSIS CENTER
Calvert, Lauren
Farsad, Mahsa
Garland, Nicole
Chaudary, Nauman
[J]. CHEST, 2021, 160 (04) : 1395A - 1395A
[4] Measuring the Impact of Food Immunotherapy on Health-Related Quality of Life in Clinical Trials
Lloyd, Melanie
Dunn Galvin, Audrey
Tang, Mimi L. K.
[J]. FRONTIERS IN ALLERGY, 2022, 3
[5] MEASURING GENERIC HEALTH-RELATED QUALITY OF LIFE AND IMPACT OF HEALTH RESOURCE UTILIZATION IN ADULTS WITH CYSTIC FIBROSIS
Yarlas, A.
O'Callaghan, L.
Lopes, V
Suthoff, E.
Wagener, J.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A503 - A503
[6] GENETIC MODIFIERS OF HEALTH-RELATED QUALITY OF LIFE IN CYSTIC FIBROSIS
Barbato, E. S.
Darrah, R.
[J]. PEDIATRIC PULMONOLOGY, 2019, 54 : S244 - S244
[7] Health-related quality of life of Spanish children with cystic fibrosis
Groeneveld, Iris F.
Sosa, Elena S.
Perez, Margarita
Fiuza-Luces, Carmen
Gonzalez-Saiz, Laura
Gallardo, Cristian
Lopez-Mojares, Luis M.
Ruiz, Jonatan R.
Lucia, Alejandro
[J]. QUALITY OF LIFE RESEARCH, 2012, 21 (10) : 1837 - 1845
[8] Health-related quality of life of Spanish children with cystic fibrosis
Iris F. Groeneveld
Elena S. Sosa
Margarita Pérez
Carmen Fiuza-Luces
Laura Gonzalez-Saiz
Cristian Gallardo
Luis M. López-Mojares
Jonatan R. Ruiz
Alejandro Lucia
[J]. Quality of Life Research, 2012, 21 : 1837 - 1845
[9] Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis
Abbott, Janice
Morton, Alison M.
Hurley, Margaret A.
Conway, Steven P.
[J]. BMJ OPEN, 2015, 5 (05):
[10] Health-related quality of life in cancer clinical trials
Trimble, EL
Rowland, J
Varricchio, C
Gore-Langton, RE
[J]. ONCOLOGY-NEW YORK, 2001, 15 (04): : 456 - +

← 1 2 3 4 5 →